VivoSeq
Other

Indocyanine Green (ICG)

0

Pipeline Programs↗

3

Active Trials↗

0

Companies Involved↗

Indocyanine Green (ICG) is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Recruiting3 · 50%
Completed2 · 33%
Unknown status1 · 17%

Clinical Trials

Trial Activity

6 trials

Micro-dosing Indocyanine Green (ICG) in Children
Recruiting·GGreat Ormond Street Hospital for Children NHS Foundation Trust·N/A·NCT06421103·90 enrolled
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
Recruiting·SSt. Jude Children's Research Hospital·Phase 1·NCT05645523·25 enrolled
Indocyanine Green (ICG) Guided Tumor Resection
Recruiting·SSt. Jude Children's Research Hospital·Phase 1·NCT04084067·230 enrolled
Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing
Completed·TTexas Tech University Health Sciences Center·N/A·NCT02766244·3 enrolled
Effect of Exercise on Indocyanine Green (ICG) Lymphography Imaging
Completed·UUniversity of Iowa·Phase 4·NCT03584633·9 enrolled
Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy
Unknown status·—·Phase 4·NCT04012476·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)